lenacapavir | EPIC Emerging & Pandemic Infections Consortium

Pre-exposure prophylaxis has emerged as a powerful strategy to deal with HIV burden, but challenges remain: a Q&A with Rupert Kaul

Dec 3, 2024

Rupert Kaul is a clinician scientist whose research focuses on mucosal immunity and HIV transmission and a world leader in HIV research and medicine December 3, 2024 By Sunitha Chari December 1, 2024, marked World AIDS Day, and forty years since the discovery of the...

Pre-exposure prophylaxis has emerged as a powerful strategy to deal with HIV burden, but challenges remain: a Q&A with Rupert Kaul

Categories

EPIC is a partnership.